ConductScience.org, home

Trial · NCT02717455

Results by group56

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Progression-free Survival (PFS) in Stratum 2Stratum 23.83Full Range 0.23 to 14.93months
Overall Survival (OS) in Stratum 2Stratum 29.13Full Range 0.23 to 20.30months
Percentage of Patients With H3F3A K27M Mutation Detected in Blood SamplesStratum 1Course 1 Day 10Percentage of participants
Percentage of Patients With H3F3A K27M Mutation Detected in Blood SamplesStratum 2Course 1 Day 15.9Percentage of participants
Percentage of Patients With H3F3A K27M Mutation Detected in Blood SamplesStratum 1Course 2 Day 10Percentage of participants
Percentage of Patients With H3F3A K27M Mutation Detected in Blood SamplesStratum 2Course 2 Day 123.1Percentage of participants
Percentage of Patients With H3F3A K27M Mutation Detected in Blood SamplesStratum 1Course 4 Day 125.0Percentage of participants
Percentage of Patients With H3F3A K27M Mutation Detected in Blood SamplesStratum 2Course 4 Day 10Percentage of participants
Percentage of Patients With H3F3A K27M Mutation Detected in Blood SamplesStratum 2Course 6 Day 120.0Percentage of participants
Percentage of Patients With Hist1H3B K27M Mutation Detected in Blood SamplesStratum 1Course 1 Day 10Percentage of participants
Percentage of Patients With Hist1H3B K27M Mutation Detected in Blood SamplesStratum 2Course 1 Day 10Percentage of participants
Percentage of Patients With Hist1H3B K27M Mutation Detected in Blood SamplesStratum 1Course 2 Day 10Percentage of participants
Percentage of Patients With Hist1H3B K27M Mutation Detected in Blood SamplesStratum 2Course 2 Day 10Percentage of participants
Percentage of Patients With Hist1H3B K27M Mutation Detected in Blood SamplesStratum 1Course 4 Day 10Percentage of participants
Percentage of Patients With Hist1H3B K27M Mutation Detected in Blood SamplesStratum 2Course 4 Day 10Percentage of participants
Percentage of Patients With Hist1H3B K27M Mutation Detected in Blood SamplesStratum 2Course 6 Day 10Percentage of participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02717455/results?page=3